Key Points
- Sophie L'helias, a Herbalife director, bought 800 shares on Dec. 1 at an average price of $12.70 (total $10,160), bringing her stake to 66,803 shares (a 1.21% increase); she also bought 400 shares on Nov. 26 at $13.22.
- Herbalife reported a quarterly EPS beat ($0.50 vs. $0.46) with revenue of $1.27B (up 4.8% YoY); the stock trades near $12.57 with a market cap of about $1.3B and a P/E of ~3.97.
- Analysts hold a consensus rating of "Moderate Buy" with a $12.75 price target, while major institutional investors (Vanguard, Long Focus, Charles Schwab, etc.) have recently increased their positions.
Herbalife Ltd (NYSE:HLF - Get Free Report) Director Sophie L'helias acquired 800 shares of the business's stock in a transaction dated Monday, December 1st. The stock was purchased at an average cost of $12.70 per share, for a total transaction of $10,160.00. Following the transaction, the director owned 66,803 shares in the company, valued at approximately $848,398.10. The trade was a 1.21% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Sophie L'helias also recently made the following trade(s):
- On Wednesday, November 26th, Sophie L'helias bought 400 shares of Herbalife stock. The shares were purchased at an average cost of $13.22 per share, with a total value of $5,288.00.
Herbalife Stock Down 1.2%
Shares of HLF opened at $12.57 on Tuesday. The company has a 50 day moving average of $9.25 and a two-hundred day moving average of $9.03. Herbalife Ltd has a twelve month low of $5.04 and a twelve month high of $13.35. The company has a market cap of $1.30 billion, a price-to-earnings ratio of 3.97, a price-to-earnings-growth ratio of 0.24 and a beta of 0.87.
Herbalife (NYSE:HLF - Get Free Report) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.46 by $0.04. The firm had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. Herbalife had a negative return on equity of 27.36% and a net margin of 6.59%.The business's revenue for the quarter was up 4.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.57 EPS. Herbalife has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. On average, sell-side analysts expect that Herbalife Ltd will post 1.57 EPS for the current year.
Hedge Funds Weigh In On Herbalife
Hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its position in Herbalife by 10.9% during the 1st quarter. Vanguard Group Inc. now owns 12,495,374 shares of the company's stock worth $107,835,000 after buying an additional 1,223,957 shares during the last quarter. Long Focus Capital Management LLC increased its stake in shares of Herbalife by 3.9% in the first quarter. Long Focus Capital Management LLC now owns 4,943,000 shares of the company's stock worth $42,658,000 after acquiring an additional 184,873 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of Herbalife by 13.4% during the first quarter. Charles Schwab Investment Management Inc. now owns 3,057,219 shares of the company's stock worth $26,384,000 after purchasing an additional 360,659 shares during the last quarter. Geode Capital Management LLC lifted its position in Herbalife by 1.1% during the second quarter. Geode Capital Management LLC now owns 2,810,794 shares of the company's stock valued at $24,231,000 after purchasing an additional 31,077 shares during the period. Finally, Iridian Asset Management LLC CT lifted its position in Herbalife by 9.9% during the third quarter. Iridian Asset Management LLC CT now owns 2,449,155 shares of the company's stock valued at $20,671,000 after purchasing an additional 220,896 shares during the period.
Analyst Ratings Changes
A number of brokerages have recently weighed in on HLF. Argus set a $15.00 price target on Herbalife in a research note on Wednesday, November 26th. Wall Street Zen upgraded shares of Herbalife from a "hold" rating to a "buy" rating in a research note on Friday. Mizuho upped their price target on shares of Herbalife from $10.00 to $11.00 and gave the company a "neutral" rating in a research note on Wednesday, November 26th. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Herbalife in a report on Wednesday, October 8th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, Herbalife presently has a consensus rating of "Moderate Buy" and a consensus price target of $12.75.
View Our Latest Analysis on Herbalife
Herbalife Company Profile
(
Get Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
